NO20024011L - Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret - Google Patents
Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaretInfo
- Publication number
- NO20024011L NO20024011L NO20024011A NO20024011A NO20024011L NO 20024011 L NO20024011 L NO 20024011L NO 20024011 A NO20024011 A NO 20024011A NO 20024011 A NO20024011 A NO 20024011A NO 20024011 L NO20024011 L NO 20024011L
- Authority
- NO
- Norway
- Prior art keywords
- prebiotic
- aid
- improve
- immune system
- enhancing
- Prior art date
Links
- 235000013406 prebiotics Nutrition 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000001720 carbohydrates Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 210000000987 immune system Anatomy 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 abstract 4
- 230000028993 immune response Effects 0.000 abstract 4
- 235000016709 nutrition Nutrition 0.000 abstract 3
- 201000005505 Measles Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract 1
- 229940107187 fructooligosaccharide Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Confectionery (AREA)
- Grain Derivatives (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00200735 | 2000-03-01 | ||
| PCT/EP2001/001627 WO2001064225A1 (en) | 2000-03-01 | 2001-02-14 | Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20024011D0 NO20024011D0 (no) | 2002-08-22 |
| NO20024011L true NO20024011L (no) | 2002-08-22 |
Family
ID=8171132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024011A NO20024011L (no) | 2000-03-01 | 2002-08-22 | Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20030040492A1 (de) |
| EP (1) | EP1261355B1 (de) |
| JP (1) | JP4838477B2 (de) |
| KR (1) | KR20020081375A (de) |
| CN (1) | CN1243551C (de) |
| AR (1) | AR027968A1 (de) |
| AT (1) | ATE283697T1 (de) |
| AU (2) | AU3174601A (de) |
| BR (1) | BR0108828A (de) |
| CA (1) | CA2400969C (de) |
| DE (1) | DE60107544T2 (de) |
| ES (1) | ES2232591T3 (de) |
| HK (1) | HK1051650A1 (de) |
| HU (1) | HUP0204546A3 (de) |
| IL (1) | IL151280A0 (de) |
| MX (1) | MXPA02008447A (de) |
| NO (1) | NO20024011L (de) |
| PL (1) | PL365136A1 (de) |
| PT (1) | PT1261355E (de) |
| UA (1) | UA73763C2 (de) |
| WO (1) | WO2001064225A1 (de) |
| ZA (1) | ZA200207849B (de) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7029702B2 (en) * | 1998-07-07 | 2006-04-18 | Ritter Natural Sciences Llc | Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| US6319252B1 (en) | 1999-07-23 | 2001-11-20 | Mcdevitt Dennis | System and method for attaching soft tissue to bone |
| KR20020043078A (ko) * | 2000-12-01 | 2002-06-08 | 한인규 | 올리고당이 포함된 복합생균제 |
| GB0229015D0 (en) | 2002-12-12 | 2003-01-15 | Novartis Nutrition Ag | New Compound |
| US8394370B2 (en) * | 2003-06-23 | 2013-03-12 | Nestec S.A. | Nutritional formula for optimal gut barrier function |
| US20050118299A1 (en) * | 2003-12-01 | 2005-06-02 | The Iams Company | Companion animal compositions comprising short chain oligofructose |
| US20050119222A1 (en) | 2003-12-01 | 2005-06-02 | The Iams Company | Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use |
| US20050118234A1 (en) * | 2003-12-01 | 2005-06-02 | The Iams Company | Methods and kits related to administration of a fructooligosaccharide |
| NO320546B1 (no) * | 2003-12-12 | 2005-12-19 | Nova Biotics As | Prebiotiske kombinasjonsprodukter |
| US20080126195A1 (en) * | 2004-07-22 | 2008-05-29 | Ritter Andrew J | Methods and Compositions for Treating Lactose Intolerance |
| US7572474B2 (en) * | 2005-06-01 | 2009-08-11 | Mead Johnson Nutrition Company | Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
| US8287931B2 (en) * | 2005-06-30 | 2012-10-16 | Mead Johnson Nutrition Company | Nutritional composition to promote healthy development and growth |
| US8075934B2 (en) * | 2008-10-24 | 2011-12-13 | Mead Johnson Nutrition Company | Nutritional composition with improved digestibility |
| JP4889262B2 (ja) * | 2005-08-19 | 2012-03-07 | 理研ビタミン株式会社 | 脂溶性薬剤組成物 |
| US20080003329A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Enriched infant formulas |
| US20100055083A1 (en) * | 2006-10-18 | 2010-03-04 | Ray Edward Kowalski | Encapsulation of heat and moisture sensitive substances |
| DE102007008664B4 (de) * | 2007-02-20 | 2021-07-29 | Vitacare Gmbh & Co. Kg | Mittel zur Anwendung bei Fructoseintoleranz |
| WO2009027039A1 (en) * | 2007-08-24 | 2009-03-05 | Barry Callebaut Ag | Process and confectionery product produced thereby |
| US20110223248A1 (en) * | 2007-12-12 | 2011-09-15 | Ritter Pharmaceuticals, Inc. | Methods and compositions for treating lactose intolerance |
| AR072141A1 (es) | 2008-06-13 | 2010-08-11 | Nutricia Nv | Composicion nutricional para lactantes nacidos por cesarea |
| WO2010008491A2 (en) * | 2008-06-25 | 2010-01-21 | Ritter Natural Sciences, Llc | Lactose compositions with decreased lactose content |
| US8986769B2 (en) * | 2008-10-24 | 2015-03-24 | Mead Johnson Nutrition Company | Methods for preserving endogenous TGF-β |
| US8425955B2 (en) * | 2009-02-12 | 2013-04-23 | Mead Johnson Nutrition Company | Nutritional composition with prebiotic component |
| CA2984935C (en) | 2009-02-24 | 2021-01-12 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| US8293264B2 (en) * | 2009-05-11 | 2012-10-23 | Mead Johnson Nutrition Company | Nutritional composition to promote healthy development and growth |
| WO2010143940A1 (en) | 2009-06-12 | 2010-12-16 | N.V. Nutricia | Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages |
| ES2433429T3 (es) | 2009-07-15 | 2013-12-11 | N.V. Nutricia | Mezcla de oligosacáridos no digeribles para estimular el sistema inmunológico |
| ES2904608T3 (es) | 2009-07-15 | 2022-04-05 | Nutricia Nv | Fucosil lactosa como oligosacárido no digerible idéntico al de la leche materna para tratar y/o prevenir la diarrea vírica |
| JP6006117B2 (ja) * | 2009-11-12 | 2016-10-12 | ネステク ソシエテ アノニム | 腸内微生物叢バランス及び健康を促進するための栄養組成物 |
| EP3202406A1 (de) | 2010-04-28 | 2017-08-09 | Ritter Pharmaceuticals, Inc. | Präbiotische formulierungen und deren verwendungen |
| US20110293784A1 (en) | 2010-05-28 | 2011-12-01 | Anja Wittke | Milk-based nutritional compositions |
| NL2007268C2 (en) | 2011-08-16 | 2013-02-19 | Friesland Brands Bv | Nutritional compositions comprising human milk oligosaccharides and uses thereof. |
| US20150086587A1 (en) * | 2012-03-28 | 2015-03-26 | Kansas State University Research Foundation | Vaccine adjuvant |
| WO2013187755A1 (en) | 2012-06-14 | 2013-12-19 | N.V. Nutricia | Fermented infant formula with non digestible oligosaccharides |
| CN103330935A (zh) * | 2013-06-17 | 2013-10-02 | 中山大学 | 果糖作为疫苗佐剂的应用 |
| US20190000873A1 (en) * | 2015-08-04 | 2019-01-03 | Südzucker AG | Prophylactic use of inulin against sinusitis |
| WO2019031961A1 (en) | 2017-08-11 | 2019-02-14 | N.V. Nutricia | OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION |
| MX2020002659A (es) | 2017-09-08 | 2020-09-09 | Evelo Biosciences Inc | Vesiculas extracelulares bacterianas. |
| BR112020004347A2 (pt) * | 2017-09-08 | 2020-09-08 | Evelo Biosciences, Inc. | vesículas extracelulares de prevotella |
| JP7469037B2 (ja) * | 2019-02-28 | 2024-04-16 | 森永乳業株式会社 | 発酵乳 |
| CN111529703B (zh) * | 2020-06-17 | 2023-09-15 | 湖南循天然营养有限公司 | 一种组合物及其制备方法与在制备免疫佐剂中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987002679A1 (en) * | 1985-10-31 | 1987-05-07 | The Australian National University | Immunotherapeutic treatment |
| US5422346A (en) * | 1988-01-06 | 1995-06-06 | California Natural Products | Instant dried dahlia inulin juice and its method of production and usage |
| DE4341780A1 (de) * | 1993-12-08 | 1995-06-14 | Suedzucker Ag | Hydrierte Fructooligosaccharide |
| EP0692252B1 (de) * | 1994-06-14 | 2001-04-04 | "Raffinerie Tirlemontoise", société anonyme: | Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel |
| EP0856259B1 (de) * | 1996-12-23 | 1998-08-12 | SITIA-YOMO S.p.A. | Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung |
| US6203797B1 (en) * | 1998-01-06 | 2001-03-20 | Stephen C. Perry | Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome |
-
2001
- 2001-02-14 IL IL15128001A patent/IL151280A0/xx unknown
- 2001-02-14 JP JP2001563122A patent/JP4838477B2/ja not_active Expired - Fee Related
- 2001-02-14 CN CNB018058973A patent/CN1243551C/zh not_active Expired - Fee Related
- 2001-02-14 AT AT01903767T patent/ATE283697T1/de not_active IP Right Cessation
- 2001-02-14 UA UA2002097766A patent/UA73763C2/uk unknown
- 2001-02-14 CA CA2400969A patent/CA2400969C/en not_active Expired - Fee Related
- 2001-02-14 KR KR1020027011308A patent/KR20020081375A/ko not_active Application Discontinuation
- 2001-02-14 BR BR0108828-9A patent/BR0108828A/pt not_active Application Discontinuation
- 2001-02-14 MX MXPA02008447A patent/MXPA02008447A/es active IP Right Grant
- 2001-02-14 AU AU3174601A patent/AU3174601A/xx active Pending
- 2001-02-14 AU AU2001231746A patent/AU2001231746C1/en not_active Ceased
- 2001-02-14 ES ES01903767T patent/ES2232591T3/es not_active Expired - Lifetime
- 2001-02-14 WO PCT/EP2001/001627 patent/WO2001064225A1/en active IP Right Grant
- 2001-02-14 PT PT01903767T patent/PT1261355E/pt unknown
- 2001-02-14 EP EP01903767A patent/EP1261355B1/de not_active Expired - Lifetime
- 2001-02-14 PL PL01365136A patent/PL365136A1/xx unknown
- 2001-02-14 HU HU0204546A patent/HUP0204546A3/hu unknown
- 2001-02-14 DE DE60107544T patent/DE60107544T2/de not_active Expired - Lifetime
- 2001-03-01 AR ARP010100985A patent/AR027968A1/es not_active Application Discontinuation
-
2002
- 2002-08-22 NO NO20024011A patent/NO20024011L/no unknown
- 2002-08-26 US US10/228,722 patent/US20030040492A1/en not_active Abandoned
- 2002-09-30 ZA ZA200207849A patent/ZA200207849B/en unknown
-
2003
- 2003-06-02 HK HK03103906A patent/HK1051650A1/xx not_active IP Right Cessation
-
2004
- 2004-04-13 US US10/822,799 patent/US7101553B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60107544T2 (de) | 2005-12-15 |
| ZA200207849B (en) | 2003-12-30 |
| ES2232591T3 (es) | 2005-06-01 |
| BR0108828A (pt) | 2002-12-10 |
| AU2001231746C1 (en) | 2005-10-06 |
| CA2400969A1 (en) | 2001-09-07 |
| JP4838477B2 (ja) | 2011-12-14 |
| CN1243551C (zh) | 2006-03-01 |
| AU3174601A (en) | 2001-09-12 |
| UA73763C2 (en) | 2005-09-15 |
| KR20020081375A (ko) | 2002-10-26 |
| CA2400969C (en) | 2011-04-19 |
| PL365136A1 (en) | 2004-12-27 |
| AR027968A1 (es) | 2003-04-16 |
| NO20024011D0 (no) | 2002-08-22 |
| HK1051650A1 (en) | 2003-08-15 |
| MXPA02008447A (es) | 2002-12-13 |
| PT1261355E (pt) | 2005-02-28 |
| HUP0204546A2 (en) | 2003-05-28 |
| WO2001064225A1 (en) | 2001-09-07 |
| US7101553B2 (en) | 2006-09-05 |
| EP1261355A1 (de) | 2002-12-04 |
| ATE283697T1 (de) | 2004-12-15 |
| US20030040492A1 (en) | 2003-02-27 |
| DE60107544D1 (de) | 2005-01-05 |
| EP1261355B1 (de) | 2004-12-01 |
| IL151280A0 (en) | 2003-04-10 |
| US20040191234A1 (en) | 2004-09-30 |
| JP2003533438A (ja) | 2003-11-11 |
| CN1422158A (zh) | 2003-06-04 |
| HUP0204546A3 (en) | 2003-10-28 |
| AU2001231746B2 (en) | 2004-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20024011L (no) | Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret | |
| SG152270A1 (en) | Immunemodulating oligosaccharides | |
| WO2005055934A3 (en) | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption | |
| NO20072733L (no) | Doseformer | |
| DE69936740D1 (de) | Oligosaccharide und Probiotica enthaltendes Präparat | |
| WO2007002836A3 (en) | Methods and compositions for the prevention and treatment of kidney disease | |
| NO20060498L (no) | Metode for a promotere benvekst | |
| NO20023473L (no) | Sammensetninger for levering av en kortisol antagonist | |
| NO20045240L (no) | Transepikutan administrasjonsform for a behandle restless legs syndromet | |
| DE602004018944D1 (de) | Verwendung von abführmittel zur behandlung des reizdarmsyndroms | |
| CA2408541A1 (en) | Treating eczema and/or psoriasis | |
| DK1196174T3 (da) | Diætmæssigt calcium, som et tilskud til D-vitamin-forbindelsesbehandling af multipel sclerose | |
| BRPI0416088A (pt) | composição, sistema, e método de tratar condições tais como calcificação vascular | |
| DK0722325T3 (da) | Præparat til behandling eller forebyggelse af herpes | |
| EP1550443A4 (de) | Zusammensetzung gegen stressbedingte erkrankungen | |
| DE60005164D1 (de) | Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion | |
| NO985695L (no) | Formulering og fremgangsmÕte for Õ behandle kongestiv hjerteinfarkt | |
| NO982854D0 (no) | Nitrogenoksyd (NO) syntetase-inhibitor for Õ behandle eller forebygge type II diabetes | |
| BR0113101A (pt) | Utilização de um inibidor de lìpases e processo e medicamento oral para tratamento, redução ou prevenção de dispepsia funcional | |
| MY127741A (en) | Wash-off vitamin e compositions | |
| BR0307196A (pt) | Idraparinux (sanorg 34006) para tratamento e profilaxia secundária de eventos tromboembólicos venosos em pacientes com trombose venosa profunda | |
| BR9507848A (pt) | Composição farmcéutica contendo espiramicina eventualmente em associação com o metronizadol | |
| WO2003032895A3 (en) | Methods and pharmaceutical compositions for stimulating the immune system and/or treating cancer | |
| BR0313046A (pt) | Uso de inibidores de quimase para prevenção e/ou tratamento de insuficiência de enxerto arteriovenoso | |
| AU2001295839A1 (en) | Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa |